This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Inflammatory condition of skin
  • /
  • S3 Guideline for the treatment of psoriasis vulgar...
Guideline

S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 2

Read time: 1 mins
Last updated:4th Jun 2018

The German guideline for the treatment of psoriasis vulgaris was updated using GRADE methodology. The guideline is based on a systematic literature review completed on December 1, 2016, and on a formal consensus and approval process. The second part of this short version of the guideline covers the following special patient populations and treatment situations: tuberculosis screening before and during psoriasis treatment, choice of psoriasis treatment for individuals wishing to have children, as well as during pregnancy and breast-feeding, and patients with joint involvement and vaccinations. In addition, recommendations on the choice of treatment are presented for patients with the following comorbidities: hepatitis and other hepatic impairment, HIV, malignancies, neurological and psychiatric disorders, ischemic heart disease and congestive heart failure, diabetes mellitus, renal impairment and inflammatory bowel disease.

 

Read full guideline